Expression and significance of Cyclin B1 in hepatocellular carcinoma by cross-species research

卢晓旭,曹骥,朱伶群,杨春,李瑗
DOI: https://doi.org/10.3969/j.issn.1673-5269.2013.20.003
2013-01-01
Abstract:OBJECTIVE: To study the expression of Cyclin B1(Ccnb1) in hepatocellular carcinoma (HCC) of different species including human, rat and tree shrew (tupaia), and to verify the feasibility of cross-species oncogenomics approach. METHODS: Real-time fluorescent quantitative polymerase chain reaction (Q-PCR) and Western Blot were applied to detect the expression levels of Cyclin B1 mRNA and protein levels in human(38 human HCC and Para-HCC tissues and 10 normal liver tissues), rat(15 HCC and Para-HCC tissues and 14 normal liver tissues), tree shrew(10 human HCC and para-HCC tissues and normal liver tissues), respectively. RESULTS: The expression of Cyclin B1 mRNA in HCC tissues of human(0.0114±0.0096) was significantly higher than that in normal liver tissues(0.0048±0.0029, P=0.033); while in HCC-adjacent tissues of human(0.0037±0.0027) was significantly lower than that in HCC tissues (P=0.002). There was no significant difference between HCC-adjacent tissues and normal liver tissues (P=0.609). The expression of Cyclin B1 mRNA in HCC tissues of rat(0.002 8±0.0019) was significantly higher than that in normal liver tissues(0.0006±0.0003, P=0.003); while in HCC-adjacent tissues of human(0.0029±0.0025) was significantly higher than that in normal liver tissues (P=0.001). There was no significant difference between HCC-adjacent tissues and HCC tissues (P=0.809). The expression of Cyclin B1 mRNA in HCC tissues of tree shew(0.014 8±0.0109) was significantly higher than that in normal liver tissues(0.0013±0.0009, P=0.007); while in HCC-adjacent tissues of human(0.0083±0.0064) it was significantly higher than that in normal liver tissues (P=0.060). There was no significant difference between HCC-adjacent tissues and HCC tissues (P=0.352). The expression of Cyclin B1 in the HCC tissue significantly correlated with the clinical stage, the Portal Vein Tumor Thrombus, the recurrence of tumor, the diameter of tumor and the differentiation of tumor, but did not correlated with the presence of extrahepatic metastasis, the number of tumor and the level of serum alpha-fetoprotein (AFP). The Western Blot analyses revealed a similar statistically significant trend. The expression of Cyclin B1 protein in HCC tissues of human(0.5707±0.2219) was significantly higher than that in HCC-adjacent tissues(0.4185±0.2543, P=0.005); while in HCC tissues it was significantly higher than that in normal liver tissues(0.3754±0.1270, P=0.019). The expression of Cyclin B1 protein in HCC tissues of rat(0.6619±0.3981) was significantly higher than that in normal liver tissues(0.3726±0.1048, P=0.039). The expression of Cyclin B1 protein in HCC tissues of tree shew(0.6563±0.2808) was significantly higher than that in HCC-adjacent tissues(0.4260±0.2015, P=0.046). CONCLUSIONS: The cross-species oncogenomics approach may represent a feasible and convenient process of identifying key molecules for human HCC. Cyclin B1 may be a particularly crucial molecule for hepatocarcinogenesis.
What problem does this paper attempt to address?